Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Serum peptide profiling (SPP) by mass spectrometry (MS) to identify postmenopausal women with metastatic breast cancer
    Meeting Abstract

    Smith, K. L.; Villanueva, J.; D'Andrea, G.; Moynahan, M. E.; Sklarin, N.; Norton, L.; Hudis, C.; Tempst, P.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Mammary cancers in mice expressing mutated Rad51
    Meeting Abstract

    Shulemovich, E.; Tornos, C.; Jasin, M.; Moynahan, M. E.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of p13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y. H.; Solit, D.; Gibbons, J.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) levels and efficacy of weekly (W) or every 3-weekly (q3W) paclitaxel (P) with or without trastuzumab (T) in patients (pts) with metastatic breast cancer (MBC): CALGB 150002/9840
    Meeting Abstract

    Seidman, A. D.; Broadwater, G.; Carney, W.; Dressler, L.; Berry, D.; Norton, L.; Hudis, C.; Winer, E.; Ellis, M.; Harris, L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Change in circulating endothelial cells (CEC) and tumor cells (CTC) in patients (pts) receiving bevacizumab and erlotinib for metastatic breast cancer (MBC) predicts stable disease at first evaluation
    Meeting Abstract

    Rugo, H. S.; Dickler, M. N.; Scott, J. H.; Moore, D. H.; Melisko, M.; Yeh, B. M.; Caravelli, J.; Brogi, E.; Hudis, C.; Park, J. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I clinical and pharmacokinetic study of weekly docetaxel followed by flavopiridol: Promising activity in metastatic pancreatic cancer
    Meeting Abstract

    Rathkopf, D.; Fornier, M.; Shah, M. A.; Kortmansky, J.; O'reilly, E.; Winkelmann, J.; Balzano, L.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Understanding racial differences in outcome from metastatic breast cancer (MBC): A pooled analysis of Cancer and Leukemia Group B (CALGB) 9342 and 9840
    Meeting Abstract

    Polite, B. N.; Cirrincione, C.; Fleming, G. F.; Berry, D. A.; Seidman, A. D.; Muss, H.; Norton, L.; Hudis, C.; Winer, E. P.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • DNA immunization against HER2/neu+ breast cancer: Evidence for a role of both antibody and T cell for optimal tumor eradication
    Meeting Abstract

    Orlandi, F.; Venanzi, F. M.; Concetti, A.; Yamauchi, J.; Wolchok, J. D.; Norton, L.; Houghton, A. N.; Gregor, P. D.
    FASEB Journal (2005)

    Fulltext@MSK | Save
  • Impact of HER2 status in breast cancer patients receiving stereotactic radiosurgery for brain metastases
    Meeting Abstract

    O'meara, W. P.; Seidman, A. D.; Yamada, Y.; McCormick, B.; Diamond, S.; Gutin, P. H.; Narayana, A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save